333 related articles for article (PubMed ID: 29569419)
1. Patients with perianal Crohn's fistulas experience delays in accessing anti-TNF therapy due to slow recognition, diagnosis and integration of specialist services: lessons learned from three referral centres.
Lee MJ; Freer C; Adegbola S; Elkady S; Parkes M; Hart A; Fearnhead NS; Lobo AJ; Brown SR
Colorectal Dis; 2018 Sep; 20(9):797-803. PubMed ID: 29569419
[TBL] [Abstract][Full Text] [Related]
2. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial.
Meima-van Praag EM; van Rijn KL; Wasmann KATGM; Snijder HJ; Stoker J; D'Haens GR; Gecse KB; Gerhards MF; Jansen JM; Dijkgraaf MGW; van der Bilt JDW; Mundt MW; Spinelli A; Danese S; Bemelman WA; Buskens CJ
Lancet Gastroenterol Hepatol; 2022 Jul; 7(7):617-626. PubMed ID: 35427495
[TBL] [Abstract][Full Text] [Related]
3. The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease.
Rayen J; Currie T; Gearry RB; Frizelle F; Eglinton T
Tech Coloproctol; 2017 Feb; 21(2):119-124. PubMed ID: 28066859
[TBL] [Abstract][Full Text] [Related]
4. Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.
Bouchard D; Abramowitz L; Bouguen G; Brochard C; Dabadie A; de Parades V; Eléouet-Kaplan M; Fathallah N; Faucheron JL; Maggiori L; Panis Y; Pigot F; Rouméguère P; Sénéjoux A; Siproudhis L; Staumont G; Suduca JM; Vinson-Bonnet B; Zeitoun JD
Tech Coloproctol; 2017 Sep; 21(9):683-691. PubMed ID: 28929282
[TBL] [Abstract][Full Text] [Related]
5. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment.
de Groof EJ; Sahami S; Lucas C; Ponsioen CY; Bemelman WA; Buskens CJ
Colorectal Dis; 2016 Jul; 18(7):667-75. PubMed ID: 26921847
[TBL] [Abstract][Full Text] [Related]
6. Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial.
de Groof EJ; Buskens CJ; Ponsioen CY; Dijkgraaf MG; D'Haens GR; Srivastava N; van Acker GJ; Jansen JM; Gerhards MF; Dijkstra G; Lange JF; Witteman BJ; Kruyt PM; Pronk A; van Tuyl SA; Bodelier A; Crolla RM; West RL; Vrijland WW; Consten EC; Brink MA; Tuynman JB; de Boer NK; Breukink SO; Pierik MJ; Oldenburg B; van der Meulen AE; Bonsing BA; Spinelli A; Danese S; Sacchi M; Warusavitarne J; Hart A; Yassin NA; Kennelly RP; Cullen GJ; Winter DC; Hawthorne AB; Torkington J; Bemelman WA
Trials; 2015 Aug; 16():366. PubMed ID: 26289163
[TBL] [Abstract][Full Text] [Related]
7. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
8. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas.
Tozer P; Ng SC; Siddiqui MR; Plamondon S; Burling D; Gupta A; Swatton A; Tripoli S; Vaizey CJ; Kamm MA; Phillips R; Hart A
Inflamm Bowel Dis; 2012 Oct; 18(10):1825-34. PubMed ID: 22223472
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
Tonelli F; Giudici F; Asteria CR
Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
[TBL] [Abstract][Full Text] [Related]
11. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease.
van Rijn KL; Lansdorp CA; Tielbeek JAW; Nio CY; Buskens CJ; D'Haens GRAM; Löwenberg M; Stoker J
Clin Imaging; 2020 Feb; 59(2):179-187. PubMed ID: 31821976
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapy.
Castaño-Milla C; Chaparro M; Saro C; Barreiro-de Acosta M; García-Albert AM; Bujanda L; Martín-Arranz MD; Carpio D; Muñoz F; Manceñido N; García-Planella E; Piqueras M; Calvet X; Cabriada JL; Botella B; Bermejo F; Gisbert JP
J Clin Gastroenterol; 2015 Jan; 49(1):34-40. PubMed ID: 25485513
[TBL] [Abstract][Full Text] [Related]
14. Examination Under Anesthesia May Not Be Universally Required Prior to Anti-TNF Therapy in Perianal Crohn's Disease: A Comparative Cohort Study.
Chan M; Fung M; Chin Koon Siw K; Khanna R; de Buck van Overstraeten A; Sabri E; McCurdy JD
Inflamm Bowel Dis; 2023 May; 29(5):763-770. PubMed ID: 35815783
[TBL] [Abstract][Full Text] [Related]
15. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.
Schwartz DA; White CM; Wise PE; Herline AJ
Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987
[TBL] [Abstract][Full Text] [Related]
16. The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort study.
Sebastian S; Black C; Pugliese D; Armuzzi A; Sahnan K; Elkady SM; Katsanos KH; Christodoulou DK; Selinger C; Maconi G; Fearnhead NS; Kopylov U; Davidov Y; Bosca-Watts MM; Ellul P; Muscat M; Karmiris K; Hart AL; Danese S; Ben-Horin S; Fiorino G
Aliment Pharmacol Ther; 2018 Nov; 48(9):941-950. PubMed ID: 30226271
[TBL] [Abstract][Full Text] [Related]
17. Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn's disease.
Yassin NA; Askari A; Warusavitarne J; Faiz OD; Athanasiou T; Phillips RK; Hart AL
Aliment Pharmacol Ther; 2014 Oct; 40(7):741-9. PubMed ID: 25115149
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.
Thomassin L; Armengol-Debeir L; Charpentier C; Bridoux V; Koning E; Savoye G; Savoye-Collet C
World J Gastroenterol; 2017 Jun; 23(23):4285-4292. PubMed ID: 28694669
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
Bor R; Farkas K; Bálint A; Szűcs M; Abrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Orv Hetil; 2013 Dec; 154(49):1943-8. PubMed ID: 24292112
[TBL] [Abstract][Full Text] [Related]
20. Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.
Plevris N; Jenkinson PW; Arnott ID; Jones GR; Lees CW
Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):32-37. PubMed ID: 31567638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
